Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.5%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$22.6B
AUM Growth
+$2.53B
(+13%)
Cap. Flow
+$1.99B
Cap. Flow
% of AUM
8.81%
Top 10 Holdings %
Top 10 Hldgs %
35.91%
Holding
1,608
New
85
Increased
1,049
Reduced
367
Closed
57
Top Buys
| 1 |
Microsoft
MSFT
|
$128M |
| 2 |
Apple
AAPL
|
$96.1M |
| 3 |
Li Auto
LI
|
$90M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$69.9M |
| 5 |
Amazon
AMZN
|
$69.6M |
Top Sells
| 1 |
NextEra Energy, Inc.
NEE
|
$57.6M |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
$37.9M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$29.2M |
| 4 |
VanEck Semiconductor ETF
SMH
|
$22.9M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
$19.6M |
Sector Composition
| 1 | Technology | 33.39% |
| 2 | Consumer Discretionary | 9.2% |
| 3 | Communication Services | 8.23% |
| 4 | Healthcare | 6.97% |
| 5 | Financials | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Savara
SVRA
$643M
| $25.2K | ﹤0.01% |
5,953
+1,827
| +44% | +$7.75K |
|
|
GOOD
1402
Gladstone Commercial Corp
GOOD
$616M
| $25.1K | ﹤0.01% |
1,555
+403
| +35% | +$6.5K |
|
1403
Westlake Corp
WLK
$11.5B
| $24.9K | ﹤0.01% |
166
-929
| -85% | -$139K |
|
1404
Pliant Therapeutics
PLRX
$114M
| $24.9K | ﹤0.01% |
2,199
+398
| +22% | +$4.5K |
|
|
DHC
1405
Diversified Healthcare Trust
DHC
$995M
| $24.6K | ﹤0.01% |
6,538
+1,691
| +35% | +$6.38K |
|
1406
CureVac
CVAC
$1.21B
| $24.3K | ﹤0.01% |
8,113
+1,416
| +21% | +$4.25K |
|
1407
Pacira BioSciences
PCRX
$1.19B
| $24.3K | ﹤0.01% |
1,668
+278
| +20% | +$4.04K |
|
1408
Humacyte
HUMA
$226M
| $24.1K | ﹤0.01% |
4,317
+762
| +21% | +$4.25K |
|
|
GMRE
1409
Global Medical REIT
GMRE
$508M
| $23.9K | ﹤0.01% |
2,418
+624
| +35% | +$6.17K |
|
1410
BILL Holdings
BILL
$5.24B
| $23.4K | ﹤0.01% |
443
+81
| +22% | +$4.27K |
|
|
UHT
1411
Universal Health Realty Income Trust
UHT
$574M
| $23.2K | ﹤0.01% |
510
+132
| +35% | +$6.01K |
|
1412
Ironwood Pharmaceuticals
IRWD
$188M
| $23.2K | ﹤0.01% |
5,777
+1,031
| +22% | +$4.15K |
|
1413
Tourmaline Bio
TRML
$687M
| $23.2K | ﹤0.01% |
927
+161
| +21% | +$4.03K |
|
|
HPP
1414
Hudson Pacific Properties
HPP
$1.16B
| $23.1K | ﹤0.01% |
4,931
+1,273
| +35% | +$5.97K |
|
1415
ACI Worldwide
ACIW
$5.19B
| $23.1K | ﹤0.01% |
454
+76
| +20% | +$3.87K |
|
1416
Braskem
BAK
$1.41B
| $22.7K | ﹤0.01% |
3,012
-1,264
| -30% | -$9.52K |
|
|
WSR
1417
Whitestone REIT
WSR
$672M
| $22.1K | ﹤0.01% |
1,648
+353
| +27% | +$4.74K |
|
1418
Allogene Therapeutics
ALLO
$255M
| $22K | ﹤0.01% |
7,563
+1,330
| +21% | +$3.87K |
|
1419
VEON
VEON
$3.8B
| $22K | ﹤0.01% |
720
| – | – |
|
|
ALX
1420
Alexander's
ALX
$1.2B
| $21.9K | ﹤0.01% |
89
+23
| +35% | +$5.65K |
|
1421
Terns Pharmaceuticals
TERN
$632M
| $21.8K | ﹤0.01% |
2,545
+614
| +32% | +$5.25K |
|
1422
Boston Beer
SAM
$2.47B
| $21.5K | ﹤0.01% |
+76
| New | +$21.5K |
|
1423
Arcturus Therapeutics
ARCT
$485M
| $21.5K | ﹤0.01% |
978
+174
| +22% | +$3.83K |
|
1424
Galapagos
GLPG
$2.2B
| $21.5K | ﹤0.01% |
733
+126
| +21% | +$3.69K |
|
1425
Mineralys Therapeutics
MLYS
$2.31B
| $21.4K | ﹤0.01% |
1,799
+317
| +21% | +$3.77K |
|